Literature DB >> 20403112

Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis.

Lisa J A Heitz-Mayfield, Niklaus P Lang.   

Abstract

This review was undertaken to address the similarities and dissimilarities between the two disease entities of periodontitis and peri-implantitis. The overall analysis of the literature on the etiology and pathogenesis of periodontitis and peri-implantitis provided an impression that these two diseases have more similarities than differences. First, the initiation of the two diseases is dependent on the presence of a biofilm containing pathogens. While the microbiota associated with periodontitis is rich in gram-negative bacteria, a similar composition has been identified in peri-implant diseases. However, increasing evidence suggests that S. aureus may be an important pathogen in the initiation of some cases of peri-implantitis. Further research into the role of this gram-positive facultative coccus, and other putative pathogens, in the development of peri-implantitis is indicated. While the initial host response to the bacterial challenge in peri-implant mucositis appears to be identical to that encountered in gingivitis, persistent biofilm accumulation may elicit a more pronounced inflammatory response in peri-implant mucosal tissues than in the dentogingival unit. This may be a result of structural differences (such as vascularity and fibroblast-to-collagen ratios). When periodontitis and peri-implantitis were produced experimentally by applying plaque-retaining ligatures, the progression of mucositis to peri-implantitis followed a very similar sequence of events as the development of gingivitis to periodontitis. However, some of the peri-implantitis lesions appeared to have periods of rapid progression, in which the infective lesion reached the alveolar bone marrow. It is therefore reasonable to assume that peri-implantitis in humans may also display periods of accelerated destruction that are more pronounced than that observed in cases of chronic periodontitis. From a clinical point of view the identified and confirmed risk factors for periodontitis may be considered as identical to those for peri-implantitis. In addition, patients susceptible to periodontitis appear to be more susceptible to peri-implantitis than patients without a history of periodontitis. As both periodontitis and peri-implantitis are opportunistic infections, their therapy must be antiinfective in nature. The same clinical principles apply to debridement of the lesions and the maintenance of an infection-free oral cavity. However, in daily practice, such principles may occasionally be difficult to apply in peri-implantitis treatment. Owing to implant surface characteristics and limited access to the microbial habitats, surgical access may be required more frequently, and at an earlier stage, in periimplantitis treatment than in periodontal therapy. In conclusion, it is evident that periodontitis and peri-implantitis are not fundamentally different from the perspectives of etiology, pathogenesis, risk assessment, diagnosis and therapy. Nevertheless, some difference in the host response to these two infections may explain the occasional rapid progression of peri-implantitis lesions. Consequently, a diagnosed peri-implantitis should be treated without delay.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20403112     DOI: 10.1111/j.1600-0757.2010.00348.x

Source DB:  PubMed          Journal:  Periodontol 2000        ISSN: 0906-6713            Impact factor:   7.589


  75 in total

1.  Peri-Implant Sulcus Fluid (PISF) Matrix Metalloproteinase (MMP) -8 Levels in Peri-Implantitis.

Authors:  René Thierbach; Kurt Maier; Timo Sorsa; Päivi Mäntylä
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  In vitro evaluation of a multispecies oral biofilm over antibacterial coated titanium surfaces.

Authors:  Javi Vilarrasa; Luis M Delgado; Marta Galofré; Gerard Àlvarez; Deborah Violant; José María Manero; Vanessa Blanc; F Javier Gil; José Nart
Journal:  J Mater Sci Mater Med       Date:  2018-11-03       Impact factor: 3.896

3.  Efficacy of various side-to-side toothbrushes for noncontact biofilm removal.

Authors:  Julia C Schmidt; Monika Astasov-Frauenhoffer; Irmgard Hauser-Gerspach; Jan-Philipp Schmidt; Tuomas Waltimo; Roland Weiger; Clemens Walter
Journal:  Clin Oral Investig       Date:  2013-07-20       Impact factor: 3.573

4.  The effects of Er:YAG on the treatment of peri-implantitis: a meta-analysis of randomized controlled trials.

Authors:  Mingdong Yan; Miaomiao Liu; Min Wang; Fengying Yin; Haibin Xia
Journal:  Lasers Med Sci       Date:  2014-11-27       Impact factor: 3.161

Review 5.  Microbiome of peri-implant infections: lessons from conventional, molecular and metagenomic analyses.

Authors:  Georgios Charalampakis; Georgios N Belibasakis
Journal:  Virulence       Date:  2015-02-05       Impact factor: 5.882

6.  Should implants be considered for patients with periodontal disease?

Authors:  E King; R Patel; A Patel; L Addy
Journal:  Br Dent J       Date:  2016-12-09       Impact factor: 1.626

Review 7.  Peri-implantitis. Part 1: Scope of the problem.

Authors:  A Alani; M Kelleher; K Bishop
Journal:  Br Dent J       Date:  2014-09       Impact factor: 1.626

8.  CSF-1 and IL-34 levels in peri-implant crevicular fluid and saliva from patients having peri-implant diseases.

Authors:  Ronaldo Lira-Junior; Mayla K S Teixeira; Eduardo J V Lourenço; Daniel M Telles; Carlos Marcelo Figueredo; Elisabeth A Boström
Journal:  Clin Oral Investig       Date:  2019-05-17       Impact factor: 3.573

Review 9.  How frequent does peri-implantitis occur? A systematic review and meta-analysis.

Authors:  Mia Rakic; Pablo Galindo-Moreno; Alberto Monje; Sandro Radovanovic; Hom-Lay Wang; David Cochran; Anton Sculean; Luigi Canullo
Journal:  Clin Oral Investig       Date:  2017-12-07       Impact factor: 3.573

10.  A Murine Model of Lipopolysaccharide-Induced Peri-Implant Mucositis and Peri-Implantitis.

Authors:  Flavia Q Pirih; Sarah Hiyari; Ho-Yin Leung; Ana D V Barroso; Adrian C A Jorge; Jeniffer Perussolo; Elisa Atti; Yi-Ling Lin; Sotirios Tetradis; Paulo M Camargo
Journal:  J Oral Implantol       Date:  2014-06-26       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.